BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15763132)

  • 1. Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation.
    Mason JN; Farmer H; Tomlinson ID; Schwartz JW; Savchenko V; DeFelice LJ; Rosenthal SJ; Blakely RD
    J Neurosci Methods; 2005 Apr; 143(1):3-25. PubMed ID: 15763132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity.
    Jørgensen S; Nielsen EØ; Peters D; Dyhring T
    J Neurosci Methods; 2008 Mar; 169(1):168-76. PubMed ID: 18222006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
    Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
    J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
    Wall SC; Gu H; Rudnick G
    Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
    Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK
    J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra.
    Paris I; Martinez-Alvarado P; Perez-Pastene C; Vieira MN; Olea-Azar C; Raisman-Vozari R; Cardenas S; Graumann R; Caviedes P; Segura-Aguilar J
    J Neurochem; 2005 Mar; 92(5):1021-32. PubMed ID: 15715653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements for 2,4- and 3,6-disubstituted pyran biomimetics of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine compounds to interact with monoamine transporters.
    Zhang S; Zhen J; Reith ME; Dutta AK
    Bioorg Med Chem; 2004 Dec; 12(23):6301-15. PubMed ID: 15519172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys.
    Ginsburg BC; Kimmel HL; Carroll FI; Goodman MM; Howell LL
    Pharmacol Biochem Behav; 2005 Mar; 80(3):481-91. PubMed ID: 15740791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
    Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH
    J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel trisubstituted asymmetric derivatives of (2S,4R,5R)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner.
    Zhang S; Zhen J; Reith ME; Dutta AK
    J Med Chem; 2005 Jul; 48(15):4962-71. PubMed ID: 16033275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship studies of highly selective inhibitors of the dopamine transporter: N-benzylpiperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine.
    Greiner E; Prisinzano T; Johnson EM; Dersch CM; Marcus J; Partilla JS; Rothman RB; Jacobson AE; Rice KC
    J Med Chem; 2003 Apr; 46(8):1465-9. PubMed ID: 12672246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperidine-based nocaine/modafinil hybrid ligands as highly potent monoamine transporter inhibitors: efficient drug discovery by rational lead hybridization.
    Zhou J; He R; Johnson KM; Ye Y; Kozikowski AP
    J Med Chem; 2004 Nov; 47(24):5821-4. PubMed ID: 15537337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to identify monoamine transporter interacting proteins.
    Torres GE; Caron MG
    J Neurosci Methods; 2005 Apr; 143(1):63-8. PubMed ID: 15763137
    [No Abstract]   [Full Text] [Related]  

  • 14. An "off-on" sensor for fluoride using luminescent CdSe/ZnS quantum dots.
    Mulrooney RC; Singh N; Kaur N; Callan JF
    Chem Commun (Camb); 2009 Feb; (6):686-8. PubMed ID: 19322422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice.
    Rothman RB; Carroll FI; Morales M; Rowley DL; Rice KC; Dersch CM; Donovan DM
    Synapse; 2002 May; 44(2):94-105. PubMed ID: 11891881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General anesthetic actions on norepinephrine, dopamine, and gamma-aminobutyric acid transporters in stably transfected cells.
    Shahani SK; Lingamaneni R; Hemmings HC
    Anesth Analg; 2002 Oct; 95(4):893-9, table of contents. PubMed ID: 12351264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine and norepinephrine transporter-dependent c-Fos production in vitro: relevance to neuroadaptation.
    Yatin SM; Miller GM; Madras BK
    J Neurosci Methods; 2005 Apr; 143(1):69-78. PubMed ID: 15763138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamine reuptake and storage. Overview.
    Bönisch H; Eiden L
    Adv Pharmacol; 1998; 42():149-64. PubMed ID: 9327868
    [No Abstract]   [Full Text] [Related]  

  • 19. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK; Sumithran SP; Dwoskin LP
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
    Mateo Y; Budygin EA; John CE; Banks ML; Jones SR
    J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.